TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, ...

Alliance News 16 May, 2024 | 4:13PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Brentford, London-based GSK said it plans to sell its 4.2% stake, around 385 million shares, in Surrey-based Haleon, the owner of brands such as Sensodyne toothpaste, which spun off from GSK in July 2022.

Haleon shares rose 0.2% to 331.84 pence each on Thursday afternoon in London, giving GSK's stake a value of around GBP1.28 billion. GSK shares fell 1.9% to 1,777.50p each.

GSK said: "The disposal announced today will be conducted through a placing of ordinary shares in Haleon to institutional investors. The offer price will be determined by means of an accelerated bookbuild offering process which is to start immediately."

Following the demerger and listing of Haleon, GSK initially retained a 13% stake in the firm. After disposals in May and October last year, that was reduced to 7.4%. GSK then sold around GBP1 billion worth of shares in January, cutting its stake further to 4.2%.

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Haleon PLC 380.60 GBX -0.44
GSK PLC 1,480.00 GBX -1.66

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures